Is Industry Influence at the FDA Putting Women at Risk? The Case of the Yasmin Advisory Committee

By ANDRE FRANCISCO

Four members of a Food and Drug Administation (FDA) board charged with evaluating the risks of birth control drugs like Yaz and Yasmin had ties to the pharmaceutical companies that made them or the generic equivalent. Not surprisingly, all four members voted that the benefits of the drugs outweighed the risks, even though the risks included potentially deadly blood clots. Check out the graphic to see the breakdown of the board's vote.

Be sure to read Adam Zagorin's story from early today that goes into the background of this story and the full letter that POGO sent FDA commission Margaret Hamburg.

Andre Francisco is POGO's online producer.

Follow @andrefrancisco